Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.7 USD | +2.48% | +10.64% | +4.04% |
05-20 | Entrada Therapeutics Insider Sold Shares Worth $287,695, According to a Recent SEC Filing | MT |
05-16 | Entrada Therapeutics Insider Bought Shares Worth $364,673, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.04% | 486M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- TRDA Stock
- News Entrada Therapeutics, Inc.
- Entrada Therapeutics Says FDA Declined to Lift Clinical Hold on Application for Phase 1 Duchenne Muscular Dystrophy Trial